CMV eVLP: Phase I ongoing

A DSMB recommended continuation of a placebo-controlled, Canadian Phase I trial evaluating unadjuvanted VBI-1501A and 3 doses of adjuvanted VBI-1501A given at months 0, 2 and 6. The trial is enrolling...